AI in Drug Development: Who’s the inventor?

AI technologies are being rapidly implemented into drug development pathways, and large pharmaceutical companies are collaborating with smaller technology groups and new start-ups to do so. Whilst these technologies are reducing the cost and time-frame associated with developing a medicine, does AI have the potential to limit a company’s monopoly right over drug discoveries?

Latest insights

More Insights
featured image

Control, Alt, Expand: The Rise and Rise of Esports in the GCC

10 minutes Jun 11 2025

Read More
featured image

4 Things to Know About Australia's New Statutory Tort of Privacy

5 minutes Jun 10 2025

Read More
featured image

A game-enhancer, not a game-changer: key takeaways on the new UAE Media Law penalties

5 minutes Jun 10 2025

Read More